PRKCF yields 563.38% · PFE yields 6.20%● Live data
📍 PRKCF pulled ahead of the other in Year 1
Combined, PRKCF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PRKCF + PFE for your $10,000?
Parker Corporation provides product development, manufacturing, sales, and technical services for the automobiles, electrical machinery, chemicals, steel, electronics, food, etc. industries in Japan and internationally. The company imports and sells machinery and equipment for use in automobile, food, shoemaking, and chemical industries. It also develops, manufactures, and sells fine chemicals for industrial use, such as cleaning agents, rust prevention, etc.; and chemical products centered on advanced chemicals, such as electronics and printing, as well as special chemicals for the aftermarket of car, railways, and aircraft. In addition, the company develops and sells industrial sealing materials and adhesives; and manufactures and sells soundproofing materials for automobile and air conditioners. Further, it develops, designs, manufactures, and sells industrial machinery. The company was formerly known as Parker Shoji Co., Ltd. and changed its name to Parker Corporation in August 1988. Parker Corporation was founded in 1951 and is headquartered in Tokyo, Japan.
Full PRKCF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.